Nuformix PLC Update re: Broker (5692G)
March 02 2018 - 08:30AM
UK Regulatory
TIDMNFX
RNS Number : 5692G
Nuformix PLC
02 March 2018
Nuformix plc
("Nuformix" or "the Company")
Update re: Broker
Nuformix (LSE: NFX.L), the pharmaceutical development company
using cocrystal technology to unlock the therapeutic potential of
approved small molecule drugs, notes the announcement today
regarding the Company's broker Beaufort Securities Limited ("BSL")
being placed into insolvency and that the Financial Conduct
Authority (the "FCA") has imposed requirements on BSL to cease all
regulatory activity. As a result BSL will no longer be able to
provide broking services to the Company and the Board is therefore
looking to make a new appointment of a broker to the Company in due
course.
Nuformix plc shares are traded on the London Stock Exchange's
Official List under the ticker: NFX.L. Follow Nuformix on Vox
Markets: follow at: www.voxmarkets.co.uk/company/NFX
and the Company's web site at: www.nuformix.com
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
ENDS
Enquiries:
Nuformix plc
Dan Gooding, Chief
Executive Officer +44 (0)1223 423667
Gable Communications
Ltd
John Bick / Justine +44 (0)20 7193
James 7463
About Nuformix plc www.nuformix.com
Nuformix is a pharmaceutical development company using cocrystal
technology to unlock the therapeutic potential of approved small
molecule drugs. Nuformix' risk-mitigated development strategy has
resulted in a pipeline of discoveries through which it has
developed and patented novel cocrystal forms of approved small
molecules.
Nuformix has created an IP portfolio containing a range of
granted patents covering cocrystal forms of five small molecule
drugs. Nuformix is targeting high-value unmet needs with its lead
programmes in oncology supportive care: NXP001 and fibrosis:
NXP002.
Nuformix was established in Cambridge in 2008 and has invested
into pharmaceutical cocrystal R&D, establishing world-class
capability and know-how in cocrystal discovery and development,
yielding multiple product opportunities. Nuformix plc shares are
traded on the London Stock Exchange's Official List under the
ticker: NFX.L.
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPEADDAEAAPEFF
(END) Dow Jones Newswires
March 02, 2018 08:30 ET (13:30 GMT)
Nuformix (LSE:NFX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nuformix (LSE:NFX)
Historical Stock Chart
From Mar 2023 to Mar 2024